Elevance Health, Inc. $ELV Stock Holdings Trimmed by GC Wealth Management RIA LLC

GC Wealth Management RIA LLC lowered its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 62.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,104 shares of the company’s stock after selling 1,860 shares during the period. GC Wealth Management RIA LLC’s holdings in Elevance Health were worth $387,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ELV. Murphy Middleton Hinkle & Parker Inc. bought a new position in shares of Elevance Health in the fourth quarter valued at about $5,941,000. Evergreen Wealth Management LLC raised its holdings in shares of Elevance Health by 33.5% in the third quarter. Evergreen Wealth Management LLC now owns 17,283 shares of the company’s stock valued at $5,584,000 after buying an additional 4,336 shares during the last quarter. Blume Capital Management Inc. raised its holdings in shares of Elevance Health by 236.7% in the third quarter. Blume Capital Management Inc. now owns 6,145 shares of the company’s stock valued at $1,986,000 after buying an additional 4,320 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of Elevance Health by 31.1% in the third quarter. Victory Capital Management Inc. now owns 461,693 shares of the company’s stock valued at $149,182,000 after buying an additional 109,462 shares during the last quarter. Finally, Synergy Asset Management LLC raised its holdings in shares of Elevance Health by 100.0% in the third quarter. Synergy Asset Management LLC now owns 104,334 shares of the company’s stock valued at $33,712,000 after buying an additional 52,167 shares during the last quarter. Institutional investors own 89.24% of the company’s stock.

Wall Street Analysts Forecast Growth

ELV has been the subject of a number of research analyst reports. Wall Street Zen cut Elevance Health from a “buy” rating to a “hold” rating in a report on Sunday, February 8th. Mizuho cut their price target on Elevance Health from $413.00 to $350.00 and set an “outperform” rating for the company in a report on Wednesday, March 11th. Leerink Partners set a $364.00 price target on Elevance Health in a report on Thursday, April 23rd. Jefferies Financial Group cut their price target on Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a report on Monday, April 20th. Finally, UBS Group set a $400.00 price objective on Elevance Health in a research report on Thursday, January 29th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $384.58.

Elevance Health Price Performance

Shares of ELV stock opened at $372.78 on Friday. The stock has a 50-day moving average price of $310.69 and a 200 day moving average price of $331.90. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.70. The firm has a market cap of $80.95 billion, a price-to-earnings ratio of 15.86, a PEG ratio of 2.14 and a beta of 0.66. Elevance Health, Inc. has a 12 month low of $273.71 and a 12 month high of $424.24.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 EPS for the quarter, topping analysts’ consensus estimates of $10.74 by $1.84. The firm had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The company’s revenue was up 1.5% on a year-over-year basis. During the same period last year, the company earned $11.97 earnings per share. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Research analysts expect that Elevance Health, Inc. will post 26.79 EPS for the current year.

Elevance Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be given a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Wednesday, June 10th. Elevance Health’s dividend payout ratio (DPR) is presently 29.26%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.